Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Chenguang Biotech Group (300138.SZ)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2022-02-28	16.84	19.00	Buy
2022-03-29	16.91	20.80	Buy
2022-04-26	14.67	21.50	Buy
2023-04-25	18.44	23.40	Buy
2023-10-24	13.36	21.30	Buy
2024-03-01	11.72	16.40	Buy
2024-08-28	7.27	9.00	Buy
2025-01-13	8.18	-	No Rating
2025-03-19	9.42	11.50	Buy
2025-04-08	11.59	13.10	Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.